Le Lézard
Classified in: Science and technology
Subject: PDT

ESD Electronics ensures VMEbus technology remains state of the art with long-term availability


HANOVER, Germany, May 16, 2022 /PRNewswire/ -- VMEbus refers to a multi-master bus system for industrial controls in 19" racks. With our many years of experience with VMEbus systems, we continuously ensure that our CPU and IO boards are adapted, therefor kept at state of the art, and the operations of long-serving installations of our customers can be guaranteed at reasonable costs. While other manufacturers are discontinuing their production of VME products, we have launched new future-proof CPU and IO boards. One requirement was that the new boards should also be compatible with the discontinued products of other market players. This allows many systems developed over a long period of time to continue to be operated in the future.

ESD electronics ensures VMEbus technology, proven reliable for over 40 years, remains up to date and state of the art

Due to its exceptionally high flexibility, the VMEbus is predestined for the operation of computer systems under real-time conditions and in harsh industrial environments such as railway engineering and maritime environments and military applications. 

The VMEbus is primarily used in applications with increased safety and reliability requirements, such as the Transrapid, the International Space Station, or the European navigation system Galileo. A strong driver for the VMEbus as a reliable and long-term system is the European Organization for Nuclear Research, better known as CERN. It continues to rely on VMEbus-based systems to control its facilities.

We develop and manufacture VMEbus boards according to customer specifications for individual applications. Our customers benefit from our many years of experience with VMEbus systems. For discontinued boards, also from other manufacturers, we offer replicas so that systems designed for the long term can continue to be operated reliably.

ESD's portfolio includes VME boards such as the VME-CPU/T10 with reliable PowerPC architecture. Mezzanine cards have been developed to extend the VMEbus via carriers. Particularly worth mentioning are the XMC-CPU/Zulu with FPGA-SoC or the PMC-CAN/402 as a high-performance CAN interface.

As part of the compatible follow-up development, we have generated the new VME-DIO32 as an easy-to-use IO card with 32 digital inputs and 32 outputs for industrial use in two versions to ensure long-term availability and bring our old VME-DPIO32 up to date with the latest technology.

ESD electronics is a member of the VMEbus International Trading Association VITAtm.
Visit our website at:  https://esd.eu/us/vme

SOURCE ESD Electronics


These press releases may also interest you

at 01:05
Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensorstm currently deployed in over 500 million devices, is shipping its AI Virtual Proximity Sensortm INNER BEAUTY® on vivo's newly announced iQOO Z9...

at 00:50
OKX, a leading Web3 technology company, has issued updates for April 25, 2024. OKX Wallet Now Integrated with XION, a User-First ...

at 00:30
Wego, the largest online travel marketplace in the Middle East and North Africa (MENA), is thrilled to announce its continued partnership with the Tourism Authority of Thailand (TAT) for the fourth consecutive year, showcasing the unparalleled beauty...

at 00:30
ENOC Group, a leading integrated global energy player, has appointed the innovative technology loyalty partner, Loyyal, to integrate Access Point, their self-service platform, into the Group's rewards programme. This move will revolutionize the 'YES'...

at 00:05
Systal Technology Solutions, a global managed network, cloud, and security transformation specialist, today announces the opening of its new Network Operations Center (NOC) in Tampa, Florida. This marks the latest milestone in Systal's recent growth...

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...



News published on and distributed by: